<SEC-DOCUMENT>0001213900-26-075528-index.html : 20260706
<SEC-HEADER>0001213900-26-075528.hdr.sgml : 20260706
<ACCEPTANCE-DATETIME>20260706163006
ACCESSION NUMBER:		0001213900-26-075528
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20260706
FILED AS OF DATE:		20260706
DATE AS OF CHANGE:		20260706

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			China SXT Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001723980
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			D8
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38773
		FILM NUMBER:		261156306

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		178 TAIDONG ROAD NORTH
		CITY:			TAIZHOU
		PROVINCE COUNTRY:   	F4
		BUSINESS PHONE:		8652386298290

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		178 TAIDONG ROAD NORTH
		CITY:			TAIZHOU
		PROVINCE COUNTRY:   	F4
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea0296876-6k_chinasxt.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
Document 1 - file: ea0296876-6k_chinasxt.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ea029687601ex10-1.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT, DATED JULY 3, 2026, BETWEEN CHINA SXT PHARMACEUTICALS INC. AND CERTAIN INSTITUTIONAL INVESTOR
<TEXT>
Document 2 - file: ea029687601ex10-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ea029687601ex10-2.htm
<DESCRIPTION>PLACEMENT AGENCY AGREEMENT, DATED JULY 3, 2026, BETWEEN CHINA SXT PHARMACEUTICALS INC. AND UNIVEST SECURITIES, LLC
<TEXT>
Document 3 - file: ea029687601ex10-2.htm

</DOCUMENT>
</SEC-DOCUMENT>